Stockreport

NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in Wet Age-Related Macular Degeneration Transcript [Seeking Alpha]

NovaBridge Biosciences - American Depositary Shares  (NBP) 
PDF Company Participants Xi-Yong Fu - CEO & Director Emmett Cunningham - Co-Founder & Executive Chairman Cadmus Rich - Chief Medical Officer Carlos Quezada-Ruiz N [Read more]